Short Interest in InfuSystem Holdings, Inc. (NYSE:INFU) Grows By 70.5%

Key Points

• InfuSystem Holdings, Inc. experienced a significant increase in short interest of 70.5% in September, with a total of 244,500 shares sold short as of September 30th.
• Insider activity includes Director Scott Shuda selling 5,752 shares at an average price of $9.67, reducing his holdings by 5.77%.
• Analysts have mixed outlooks on InfuSystem, with Zacks Research downgrading it to a "hold" rating, while Lake Street Capital maintains a "buy" rating with a price target of $15.00.

InfuSystem Holdings, Inc. (NYSE:INFU - Get Free Report) was the recipient of a large growth in short interest in the month of September. As of September 30th, there was short interest totaling 244,500 shares, a growth of 70.5% from the September 15th total of 143,400 shares. Based on an average daily volume of 248,100 shares, the short-interest ratio is presently 1.0 days. Currently, 1.3% of the company's stock are sold short. Currently, 1.3% of the company's stock are sold short. Based on an average daily volume of 248,100 shares, the short-interest ratio is presently 1.0 days.

Insider Buying and Selling at InfuSystem

In other news, Director Scott Shuda sold 5,752 shares of the company's stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $9.67, for a total value of $55,621.84. Following the completion of the sale, the director owned 94,000 shares of the company's stock, valued at approximately $908,980. This represents a 5.77% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 11.40% of the company's stock.

Hedge Funds Weigh In On InfuSystem

A number of hedge funds have recently added to or reduced their stakes in INFU. ARS Investment Partners LLC bought a new stake in shares of InfuSystem during the third quarter valued at about $117,000. Brevan Howard Capital Management LP acquired a new stake in InfuSystem during the 2nd quarter worth about $228,000. Bank of America Corp DE raised its holdings in InfuSystem by 19.4% during the 2nd quarter. Bank of America Corp DE now owns 17,994 shares of the company's stock worth $112,000 after buying an additional 2,924 shares during the period. Ameriprise Financial Inc. raised its holdings in InfuSystem by 82.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 130,350 shares of the company's stock worth $813,000 after buying an additional 58,810 shares during the period. Finally, Jane Street Group LLC grew its stake in InfuSystem by 943.1% during the 2nd quarter. Jane Street Group LLC now owns 186,159 shares of the company's stock valued at $1,162,000 after acquiring an additional 168,312 shares in the last quarter. Institutional investors and hedge funds own 71.13% of the company's stock.

Wall Street Analyst Weigh In

INFU has been the topic of several analyst reports. Zacks Research lowered shares of InfuSystem from a "strong-buy" rating to a "hold" rating in a research report on Monday, October 6th. Lake Street Capital started coverage on shares of InfuSystem in a research note on Monday, September 22nd. They issued a "buy" rating and a $15.00 price target on the stock. Finally, Roth Capital started coverage on shares of InfuSystem in a research note on Tuesday, July 22nd. They set a "buy" rating and a $12.00 target price on the stock. Three research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Buy" and a consensus price target of $13.50.

InfuSystem Trading Up 2.8%

Shares of INFU traded up $0.27 during mid-day trading on Thursday, hitting $10.06. The company had a trading volume of 144,493 shares, compared to its average volume of 186,324. InfuSystem has a 1-year low of $4.61 and a 1-year high of $11.04. The business's 50-day simple moving average is $10.01 and its 200-day simple moving average is $7.29. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50. The stock has a market cap of $205.49 million, a PE ratio of 167.69 and a beta of 1.79.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.